首页 > 最新文献

Journal of Infection Prevention最新文献

英文 中文
Designing an optimal infection prevention service: Part 1. 设计最佳的感染预防服务:第 1 部分.
IF 1.2 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 Epub Date: 2022-09-21 DOI: 10.1177/17571774221127695
Emma Burnett, Tracey Cooper, Karen Wares, Neil Wigglesworth, Lilian Chiwera, Chris Settle, Jude Robinson

Background: Healthcare-associated infections (HCAIs) pose a significant threat to the health and safety of patients, staff, and visitors. Infection prevention and control (IPC) teams play a crucial role in ensuring that systems and processes are in place to keep everyone safe within the healthcare environment.

Aim: The aim of this study was to identify components of infection prevention services, priorities, indicators of successes and how they are measured, and facilitators and barriers to success.

Methods: A survey questionnaire was developed and circulated to infection prevention leaders and managers.

Findings/results: Seventy IPC leaders/managers completed the survey. Participants were responsible for a range of IPC services within and across healthcare organisations, with significant variations to IPC delivery components. Additionally, a range of budget availability was reported. Several IPC service requirements were considered core work of IPC teams, including providing IPC advice and support, surveillance and audit and education and training.

Discussion: An optimal IPC service needs to be in place to ensure HCAIs are minimised or prevented. In a post pandemic era, this is more important than ever before. This is also as crucial for the health and wellbeing of those working in IPC, who have endured unprecedented demand for their services during the pandemic.

背景:医疗相关感染(HCAIs)对患者、员工和来访者的健康和安全构成重大威胁。感染预防与控制(IPC)团队在确保系统和流程到位以保证医疗环境中每个人的安全方面发挥着至关重要的作用。目的:本研究旨在确定感染预防服务的组成部分、优先事项、成功指标和衡量方法,以及成功的促进因素和障碍:方法:编制调查问卷并分发给感染预防领导者和管理者:70 位感染预防领导/管理人员完成了调查。参与调查的人员负责医疗机构内部和医疗机构之间的一系列 IPC 服务,IPC 的实施内容存在很大差异。此外,还报告了各种预算可用性。一些 IPC 服务要求被认为是 IPC 团队的核心工作,包括提供 IPC 建议和支持、监督和审计以及教育和培训:讨论:为确保最大限度地减少或预防 HCAI,需要提供最佳的 IPC 服务。在后大流行病时代,这一点比以往任何时候都更加重要。这对于从事 IPC 工作的人员的健康和福祉也同样至关重要,因为在大流行期间,对他们的服务需求是前所未有的。
{"title":"Designing an optimal infection prevention service: Part 1.","authors":"Emma Burnett, Tracey Cooper, Karen Wares, Neil Wigglesworth, Lilian Chiwera, Chris Settle, Jude Robinson","doi":"10.1177/17571774221127695","DOIUrl":"10.1177/17571774221127695","url":null,"abstract":"<p><strong>Background: </strong>Healthcare-associated infections (HCAIs) pose a significant threat to the health and safety of patients, staff, and visitors. Infection prevention and control (IPC) teams play a crucial role in ensuring that systems and processes are in place to keep everyone safe within the healthcare environment.</p><p><strong>Aim: </strong>The aim of this study was to identify components of infection prevention services, priorities, indicators of successes and how they are measured, and facilitators and barriers to success.</p><p><strong>Methods: </strong>A <i>s</i>urvey questionnaire was developed and circulated to infection prevention leaders and managers.</p><p><strong>Findings/results: </strong>Seventy IPC leaders/managers completed the survey. Participants were responsible for a range of IPC services within and across healthcare organisations, with significant variations to IPC delivery components. Additionally, a range of budget availability was reported. Several IPC service requirements were considered core work of IPC teams, including providing IPC advice and support, surveillance and audit and education and training.</p><p><strong>Discussion: </strong>An optimal IPC service needs to be in place to ensure HCAIs are minimised or prevented. In a post pandemic era, this is more important than ever before. This is also as crucial for the health and wellbeing of those working in IPC, who have endured unprecedented demand for their services during the pandemic.</p>","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":"24 1","pages":"3-10"},"PeriodicalIF":1.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834424/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10527399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduction in cycle time for a rapid polymerase chain reaction diagnostic test at the point of care. 缩短护理点快速聚合酶链反应诊断试验的周期时间。
IF 1.2 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.1177/17571774221148072
Lochana Nanayakkara, Talia R Pettigrew, Jenny Overton, Paul L Ryan, Avaneet K Pawar, Hebe M Midson, Mark J Coldwell, Joanne E Martin

Background: Rapid testing facilitates safe and effective diagnosis, but the true speed of the process is the time from collection of a sample to delivery of an accurate and reliable test result - 'end-to-end' time. Transport, unpacking and relaying of information can extend this time considerably beyond the minimum laboratory turnaround times as stipulated by PCR testing protocols.

Aim/objective: This study aimed to minimise time needed to ascertain SARS-CoV-2 status prior to treatment in a UK Dental Hospital using a novel, mobile, direct to polymerase chain reaction (PCR) workflow.

Methods: Process flow analysis and PDSA (Plan, Do, Study, Act) cycles for rapid continuous improvement were employed in a service improvement programme. Primerdesign™ q16 rapid PCR instruments and PROmate® COVID-19 direct assays were used for molecular testing.

Findings/results: We showed a reduction in real-world end-to-end time for a diagnostic test from 240 min to 85 min (65% reduction) over a 4-week period.

Discussion: New rapid technologies have become available that reduce analytical time to under 90 min, but the real-world clinical implementation of the test requires a fully integrated workflow from clinic to reporting.

背景:快速检测有助于安全有效的诊断,但该过程的真正速度是从收集样本到提供准确可靠的检测结果的时间——“端到端”时间。运输、拆包和传递信息可大大延长这一时间,超出PCR检测协议规定的最短实验室周转时间。目的/目的:本研究旨在使用一种新颖的、可移动的、直接到聚合酶链反应(PCR)的工作流程,最大限度地减少在英国牙科医院治疗前确定SARS-CoV-2状态所需的时间。方法:采用流程流分析和PDSA(计划、实施、研究、行动)循环进行快速持续改进。采用Primerdesign™q16快速PCR仪和PROmate®COVID-19直接测定法进行分子检测。发现/结果:我们发现,在4周的时间内,诊断测试的实际端到端时间从240分钟减少到85分钟(减少65%)。讨论:新的快速技术已经可用,可以将分析时间减少到90分钟以下,但是实际的临床实施测试需要从临床到报告的完全集成的工作流程。
{"title":"Reduction in cycle time for a rapid polymerase chain reaction diagnostic test at the point of care.","authors":"Lochana Nanayakkara,&nbsp;Talia R Pettigrew,&nbsp;Jenny Overton,&nbsp;Paul L Ryan,&nbsp;Avaneet K Pawar,&nbsp;Hebe M Midson,&nbsp;Mark J Coldwell,&nbsp;Joanne E Martin","doi":"10.1177/17571774221148072","DOIUrl":"https://doi.org/10.1177/17571774221148072","url":null,"abstract":"<p><strong>Background: </strong>Rapid testing facilitates safe and effective diagnosis, but the true speed of the process is the time from collection of a sample to delivery of an accurate and reliable test result - 'end-to-end' time. Transport, unpacking and relaying of information can extend this time considerably beyond the minimum laboratory turnaround times as stipulated by PCR testing protocols.</p><p><strong>Aim/objective: </strong>This study aimed to minimise time needed to ascertain SARS-CoV-2 status prior to treatment in a UK Dental Hospital using a novel, mobile, direct to polymerase chain reaction (PCR) workflow.</p><p><strong>Methods: </strong>Process flow analysis and PDSA (Plan, Do, Study, Act) cycles for rapid continuous improvement were employed in a service improvement programme. Primerdesign™ q16 rapid PCR instruments and PROmate® COVID-19 direct assays were used for molecular testing.</p><p><strong>Findings/results: </strong>We showed a reduction in real-world end-to-end time for a diagnostic test from 240 min to 85 min (65% reduction) over a 4-week period.</p><p><strong>Discussion: </strong>New rapid technologies have become available that reduce analytical time to under 90 min, but the real-world clinical implementation of the test requires a fully integrated workflow from clinic to reporting.</p>","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":"24 1","pages":"23-29"},"PeriodicalIF":1.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10581857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Implementing an infection control checklist May not be effective in reducing the incidence of surgical site infections in spinal surgery. 实施感染控制检查表可能无法有效降低脊柱手术中手术部位感染的发生率。
IF 1.2 Q4 INFECTIOUS DISEASES Pub Date : 2022-11-01 Epub Date: 2022-09-14 DOI: 10.1177/17571774221127620
Gizem Kavak, Cihan Kırçıl, Hatice Pelgur, Eylem Topçu, Evrim Yanmaz Erdoğmuş, Tuba Ayabakan, Emre R Acaroglu

Background: Surgical site infections (SSI) in instrumented spine surgery remains as a major complication with increased morbidity. Although implementation of surgical safety checklists has been reported to lower the rates of SSI, reproducibility of these remain unclear.

Objective: The specific aim of this study was to explore the results of implementation of a SSI control protocol in regard to its efficacy in decreasing the rate of SSI.

Methods: A total of 140 instrumented spinal surgery cases between 2018 and 2021 were divided into two groups as Group 1 (checklist implemented) and Group 2 (control) and these were compared regarding SSI rates, patient rand surgery related factors, laboratory findings and infecting microorganisms.

Results: Ten SSIs were encountered in Group 1 (20.8%), whereas only nine in Group 2 (9.8%). Although not statistically significant (p > .05), these results highly favor the non-checklist implemented group regarding the development of SSI. A definitive infective microorganism could be identified in five out of 10 SSI in Group 1 and 6 out of nine in Group 2. Whereas only three out of 11 (27.3%) involved Gr (+) agents, rest of eight out of 11 (72.7%) involved Gr (-) agents.

Discussion: A failure in decreasing the SSI rate through the implementation of a SSI prevention checklist may be due to several factors pertaining to the study design, patient characteristics and the Gr (-) dominance in SSIs in our center. Nevertheless, this suggests that checklist implementation to prevent SSI in instrumented spine surgery may not be effective in all contexts.

背景:器械脊柱手术中的手术部位感染(SSI)仍然是发病率增加的主要并发症。尽管有报道称,实施手术安全检查表可以降低SSI的发生率,但其再现性仍不清楚。目的:本研究的具体目的是探讨SSI控制方案在降低SSI发生率方面的效果,患者rand手术相关因素、实验室检查结果和感染微生物。结果:第1组有10例SSI(20.8%),而第2组只有9例(9.8%)。尽管没有统计学意义(p>0.05),但这些结果在SSI的发展方面高度支持未执行检查表的组。在第1组的10个SSI中有5个和第2组的9个中有6个可以鉴定出明确的感染微生物。11人中只有3人(27.3%)涉及Gr(+)制剂,其余8人(72.7%)涉及Gr-制剂。讨论:通过实施SSI预防检查表来降低SSI率的失败可能是由于与研究设计、患者特征和我们中心SSI中Gr(-)占主导地位有关的几个因素。然而,这表明,在器械脊柱手术中预防SSI的检查表实施可能并非在所有情况下都有效。
{"title":"Implementing an infection control checklist May not be effective in reducing the incidence of surgical site infections in spinal surgery.","authors":"Gizem Kavak,&nbsp;Cihan Kırçıl,&nbsp;Hatice Pelgur,&nbsp;Eylem Topçu,&nbsp;Evrim Yanmaz Erdoğmuş,&nbsp;Tuba Ayabakan,&nbsp;Emre R Acaroglu","doi":"10.1177/17571774221127620","DOIUrl":"10.1177/17571774221127620","url":null,"abstract":"<p><strong>Background: </strong>Surgical site infections (SSI) in instrumented spine surgery remains as a major complication with increased morbidity. Although implementation of surgical safety checklists has been reported to lower the rates of SSI, reproducibility of these remain unclear.</p><p><strong>Objective: </strong>The specific aim of this study was to explore the results of implementation of a SSI control protocol in regard to its efficacy in decreasing the rate of SSI.</p><p><strong>Methods: </strong>A total of 140 instrumented spinal surgery cases between 2018 and 2021 were divided into two groups as Group 1 (checklist implemented) and Group 2 (control) and these were compared regarding SSI rates, patient rand surgery related factors, laboratory findings and infecting microorganisms.</p><p><strong>Results: </strong>Ten SSIs were encountered in Group 1 (20.8%), whereas only nine in Group 2 (9.8%). Although not statistically significant (<i>p</i> > .05), these results highly favor the non-checklist implemented group regarding the development of SSI. A definitive infective microorganism could be identified in five out of 10 SSI in Group 1 and 6 out of nine in Group 2. Whereas only three out of 11 (27.3%) involved Gr (+) agents, rest of eight out of 11 (72.7%) involved Gr (-) agents.</p><p><strong>Discussion: </strong>A failure in decreasing the SSI rate through the implementation of a SSI prevention checklist may be due to several factors pertaining to the study design, patient characteristics and the Gr (-) dominance in SSIs in our center. Nevertheless, this suggests that checklist implementation to prevent SSI in instrumented spine surgery may not be effective in all contexts.</p>","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":"23 6","pages":"269-277"},"PeriodicalIF":1.2,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40566398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diary. 记事簿
IF 1.2 Q4 INFECTIOUS DISEASES Pub Date : 2022-11-01 Epub Date: 2022-10-18 DOI: 10.1177/17571774221126783
{"title":"Diary.","authors":"","doi":"10.1177/17571774221126783","DOIUrl":"10.1177/17571774221126783","url":null,"abstract":"","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":"23 6","pages":"296"},"PeriodicalIF":1.2,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583442/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40566399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nosocomial COVID-19, a risk illustrated by the first in-hospital transmission of B.1.1.7 variant of SARS-CoV-2 in a French University Hospital. 医院源性COVID-19:法国一所大学医院首次出现SARS-CoV-2 B.1.1.7变体的院内传播,说明了这一风险。
IF 1.2 Q4 INFECTIOUS DISEASES Pub Date : 2022-11-01 Epub Date: 2022-09-14 DOI: 10.1177/17571774221127543
Clément Legeay, Caroline Lefeuvre

Objectives: In this short report, we describe the first nosocomial spread of B.1.1.7 variant (GR/20I/501Y.V1) in a French hospital, underlining the different aspects of in-hospital transmission of SARS-CoV-2.

Patients and methods: Retrospective study of a SARS-CoV-2 cluster investigation in January 2021. All cases were screened with RT-PCR.

Results: First transmission occurred in a double room with a COVID-19 imported cases, undetected upon admission. Healthcare workers, their relatives and patients' relatives were screened. Eleven secondary cases were identified within a week, in and out of the hospital (in hospital attack rate: 3.1%). No severe COVID-19 was encountered.

Conclusions: This report highlights several in-hospital chains of transmission involved with COVID-19 with rapid spread.

目的:在这篇简短的报告中,我们描述了B.1.1.7变体(GR/20I/501Y.V1)在法国一家医院的首次院内传播,强调了SARS-CoV-2院内传播的不同方面。患者和方法:对2021年1月一起SARS-CoV-2聚集性调查的回顾性研究。所有病例均采用RT-PCR筛查。结果:首次传播发生在一间双人间,入院时未发现一例新冠肺炎输入病例。对医护人员、其亲属和患者亲属进行了筛查。11例继发性病例在一周内发现,包括院内和院外(院内发病率:3.1%)。未遇到严重COVID-19。结论:本报告强调了与COVID-19快速传播有关的几个医院内传播链。
{"title":"Nosocomial COVID-19, a risk illustrated by the first in-hospital transmission of B.1.1.7 variant of SARS-CoV-2 in a French University Hospital.","authors":"Clément Legeay,&nbsp;Caroline Lefeuvre","doi":"10.1177/17571774221127543","DOIUrl":"https://doi.org/10.1177/17571774221127543","url":null,"abstract":"<p><strong>Objectives: </strong>In this short report, we describe the first nosocomial spread of B.1.1.7 variant (GR/20I/501Y.V1) in a French hospital, underlining the different aspects of in-hospital transmission of SARS-CoV-2.</p><p><strong>Patients and methods: </strong>Retrospective study of a SARS-CoV-2 cluster investigation in January 2021. All cases were screened with RT-PCR.</p><p><strong>Results: </strong>First transmission occurred in a double room with a COVID-19 imported cases, undetected upon admission. Healthcare workers, their relatives and patients' relatives were screened. Eleven secondary cases were identified within a week, in and out of the hospital (in hospital attack rate: 3.1%). No severe COVID-19 was encountered.</p><p><strong>Conclusions: </strong>This report highlights several in-hospital chains of transmission involved with COVID-19 with rapid spread.</p>","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":"23 6","pages":"293-295"},"PeriodicalIF":1.2,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40568891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Incidence and risk factors of surgical site infections after coronary artery bypass grafting surgery in Oman. 阿曼冠状动脉搭桥术后手术部位感染的发生率和危险因素。
IF 1.2 Q4 INFECTIOUS DISEASES Pub Date : 2022-11-01 Epub Date: 2022-09-27 DOI: 10.1177/17571774221127553
Fatma M AlRiyami, Omar M Al-Rawajfah, Sulaiman Al Sabei, Hilal A Al Sabti

Background: There is limited information about the incidence and risk factors of surgical site infections (SSIs) after coronary artery bypass (CABG) surgeries in the Omani population.

Aim: To estimate the prevalence and describe possible risk factors of SSIs after CABG surgeries in Oman.

Method: A retrospective nested case-control design was used to screen 596 patients who underwent CABG surgeries over 2 years (2016-2017) in two tertiary hospitals in Oman. The CDC definition for SSIs was used to identify the infected cases.

Results: Prevalence rate of SSIs was 17.4% and 17.5% in 2016 and 2017, respectively. The most isolated microorganism was Gram-positive bacteria (45.2%). Risk factors of SSIs include female gender (OR = 3.2, p < 0.001), diabetes (OR = 5.83, p < 0.001), overweight or obese (OR = 2.14, p < 0.05) and shaving technique [using razor shaving] (OR = 8.4, p < 0.001). Readmission rate for the case group was 44.2%.

Conclusion: The infection rate of SSIs after CABG surgeries in developing countries, such as Oman, is considerably high. There is an urgent need to establish SSIs preventive program at the national level. Frequent and systematic assessment of infection control practices before and after CABG surgeries is fundamental and priority strategy to prevent SSIs.

背景:关于阿曼人群冠状动脉搭桥术后手术部位感染(SSIs)的发生率和危险因素的信息有限。目的:评估阿曼冠状动脉旁路移植术后SSIs的患病率并描述可能的风险因素。方法:采用回顾性嵌套病例对照设计,对阿曼两家三级医院在2年(2016-2017年)内接受冠状动脉旁路植入术的596名患者进行筛查。疾病控制与预防中心对SSIs的定义用于识别感染病例。结果:2016年和2017年SSIs的患病率分别为17.4%和17.5%。分离最多的微生物是革兰氏阳性菌(45.2%)。SSIs的危险因素包括女性(OR=3.2,p<0.001)、糖尿病(OR=5.83,p<0.001),超重或肥胖(or=2.14,p<0.05)和剃须技术(or=8.4,p<0.001)。病例组的复发率为44.2%。结论:在阿曼等发展中国家,CABG手术后SSIs的感染率相当高。迫切需要在国家一级建立SSIs预防计划。CABG手术前后对感染控制实践进行频繁和系统的评估是预防SSI的基本和优先策略。
{"title":"Incidence and risk factors of surgical site infections after coronary artery bypass grafting surgery in Oman.","authors":"Fatma M AlRiyami,&nbsp;Omar M Al-Rawajfah,&nbsp;Sulaiman Al Sabei,&nbsp;Hilal A Al Sabti","doi":"10.1177/17571774221127553","DOIUrl":"10.1177/17571774221127553","url":null,"abstract":"<p><strong>Background: </strong>There is limited information about the incidence and risk factors of surgical site infections (SSIs) after coronary artery bypass (CABG) surgeries in the Omani population.</p><p><strong>Aim: </strong>To estimate the prevalence and describe possible risk factors of SSIs after CABG surgeries in Oman.</p><p><strong>Method: </strong>A retrospective nested case-control design was used to screen 596 patients who underwent CABG surgeries over 2 years (2016-2017) in two tertiary hospitals in Oman. The CDC definition for SSIs was used to identify the infected cases.</p><p><strong>Results: </strong>Prevalence rate of SSIs was 17.4% and 17.5% in 2016 and 2017, respectively. The most isolated microorganism was Gram-positive bacteria (45.2%). Risk factors of SSIs include female gender (OR = 3.2, <i>p</i> < 0.001), diabetes (OR = 5.83, <i>p</i> < 0.001), overweight or obese (OR = 2.14, <i>p</i> < 0.05) and shaving technique [using razor shaving] (OR = 8.4, <i>p</i> < 0.001). Readmission rate for the case group was 44.2%.</p><p><strong>Conclusion: </strong>The infection rate of SSIs after CABG surgeries in developing countries, such as Oman, is considerably high. There is an urgent need to establish SSIs preventive program at the national level. Frequent and systematic assessment of infection control practices before and after CABG surgeries is fundamental and priority strategy to prevent SSIs.</p>","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":"23 6","pages":"285-292"},"PeriodicalIF":1.2,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583440/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40568892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Gender disparity and stigma experience of patients with chronic hepatitis B virus infection: A prospective cross-sectional study from a hospital in Nigeria. 慢性乙型肝炎病毒感染患者的性别差异和耻辱经历:尼日利亚一家医院的前瞻性横断面研究。
IF 1.2 Q4 INFECTIOUS DISEASES Pub Date : 2022-11-01 Epub Date: 2022-09-14 DOI: 10.1177/17571774221127546
Olusegun Adekanle, Akinwumi Oluwole Komolafe, Oluwasegun Ijarotimi, Anu Samuel Olowookere, Dennis A Ndububa

Backgound: Hepatitis B virus (HBV) infected persons often suffer stigma. Stigma can come from the society or be self-induced. This study assessed the gender differences and stigma experience of patients with HBV.

Methods: Prospective cross-sectional design with a qualitative element using a pretested interviewer administered questionnaire and an in-depth oral interview of HBV infected patients. Quantitative data obtained were entered into SPSS version 20 and analyzed using simple descriptive and inferential statistics, while content analysis was used for the qualitative data.

Results: Total of 242 respondents answered the quantitative questionnaire. There were 142(58.7%) males and 100 (41.3%) females; age range was 18-72 years with mean (SD) of 35.4(10.7) years. Overall stigma rate was 23.1%. Stigma resulted from a positive HBsAg test, and the experience was unaffected by other markers of HBV infection. Stigma was higher in the domain of disease transmission for both single and married respondents and was particularly higher among males than females. Stigma among females affected pre-marital engagements and also caused marital disharmony among married respondents. In-depth oral interview of 23 HBV infected respondents revealed that many exhibited self-stigma, had wrong knowledge of HBV infection modes, complications, and interpretation of HBV internet information which aggravated stigma reactions.

Conclusions: Stigma of HBV is high and majorly in the domain of disease transmission. It is higher in males than females. Enlightenment campaign targeting singles and married couples and HBV infection modes is advocated.

背景:乙型肝炎病毒(HBV)感染者经常遭受耻辱。耻辱可以来自社会,也可以是自我造成的。本研究评估了HBV感染者的性别差异和耻辱经历。将获得的定量数据输入SPSS 20版本,并使用简单的描述性和推断统计学进行分析,而定性数据则使用内容分析。结果:共有242名受访者回答了定量问卷。男性142例(58.7%),女性100例(41.3%);年龄范围为18-72岁,平均(SD)为35.4(10.7)岁。总体污名率为23.1%。污名是由HBsAg检测呈阳性引起的,这种经历不受其他HBV感染标志物的影响。单身和已婚受访者在疾病传播领域的耻辱感更高,男性比女性更高。女性的耻辱影响了婚前约会,也导致已婚受访者的婚姻不和谐。对23名HBV感染者的深入口头访谈显示,许多人表现出自我污名,对HBV感染模式、并发症和对HBV互联网信息的解释有错误的认识,这些都加剧了污名反应。结论:乙型肝炎病毒的污名性较高,且主要在疾病传播领域。男性的发病率高于女性。倡导针对单身和已婚夫妇以及HBV感染模式的启蒙运动。
{"title":"Gender disparity and stigma experience of patients with chronic hepatitis B virus infection: A prospective cross-sectional study from a hospital in Nigeria.","authors":"Olusegun Adekanle,&nbsp;Akinwumi Oluwole Komolafe,&nbsp;Oluwasegun Ijarotimi,&nbsp;Anu Samuel Olowookere,&nbsp;Dennis A Ndububa","doi":"10.1177/17571774221127546","DOIUrl":"10.1177/17571774221127546","url":null,"abstract":"<p><strong>Backgound: </strong>Hepatitis B virus (HBV) infected persons often suffer stigma. Stigma can come from the society or be self-induced. This study assessed the gender differences and stigma experience of patients with HBV.</p><p><strong>Methods: </strong>Prospective cross-sectional design with a qualitative element using a pretested interviewer administered questionnaire and an in-depth oral interview of HBV infected patients. Quantitative data obtained were entered into SPSS version 20 and analyzed using simple descriptive and inferential statistics, while content analysis was used for the qualitative data.</p><p><strong>Results: </strong>Total of 242 respondents answered the quantitative questionnaire. There were 142(58.7%) males and 100 (41.3%) females; age range was 18-72 years with mean (SD) of 35.4(10.7) years. Overall stigma rate was 23.1%. Stigma resulted from a positive HBsAg test, and the experience was unaffected by other markers of HBV infection. Stigma was higher in the domain of disease transmission for both single and married respondents and was particularly higher among males than females. Stigma among females affected pre-marital engagements and also caused marital disharmony among married respondents. In-depth oral interview of 23 HBV infected respondents revealed that many exhibited self-stigma, had wrong knowledge of HBV infection modes, complications, and interpretation of HBV internet information which aggravated stigma reactions.</p><p><strong>Conclusions: </strong>Stigma of HBV is high and majorly in the domain of disease transmission. It is higher in males than females. Enlightenment campaign targeting singles and married couples and HBV infection modes is advocated.</p>","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":"23 6","pages":"263-268"},"PeriodicalIF":1.2,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40566397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuberculosis in elderly: Epidemiological profile, prognosis factors and chronological trends in Southern Tunisia, 1995-2016. 老年人结核病:1995-2016年突尼斯南部的流行病学概况、预后因素和时间趋势。
IF 1.2 Q4 INFECTIOUS DISEASES Pub Date : 2022-11-01 Epub Date: 2022-09-15 DOI: 10.1177/17571774221127540
Maroua Trigui, Houda Ben Ayed, Makram Koubaa, Mariem Ben Hmida, Maissa Ben Jmaa, Sourour Yaich, Tarek Ben Jmaa, Fatma Hammami, Habib Fki, Jamel Damak, Mounir Ben Jemaa

Background: Tuberculosis (TB) has become a public health problem among elderly in developing countries with the gradual increase in life expectancy.

Aim/objective: This study aimed to analyze the prognosis factors and chronological trends of TB in elderly in Southern Tunisia.

Methods: A retrospective study was conducted. All TB patients aged ≥60 years, recorded in the Center of TB Control between 1995 and 2016, were included. Chronological trends of TB were analyzed by calculating the correlation coefficient of Spearman (Rho). Multivariate analysis was done by binary logistic regression (Adjusted Odds ratio (AOR); CI; p) to determine the independent risk factors associated with unsuccessful outcome in elderly. A p value <0.05 was considered as statistically significant.

Results: Overall, 512 new elderly TB cases were notified between 1995 and 2016, with an average of 23.3 new cases/year. The mean TB incidence rate for elderly was 2.31/100,000 population/year. The case-fatality rate of 8.6%. Multivariate analysis showed that factors independently associated with unsuccessful outcome among elderly patients were age between 80 and 89 (AOR = 4.5; [95% CI: 2, 10.2]; p < 0.001), male gender (AOR = 2.2; [95% CI: 1.1, 4.4]; p = 0.026) and neuro-meningeal involvement (AOR = 4.6; [95% CI: 1.4, 14.8]; p = 0.011). The incidence of TB in elderly patients increased significantly from 0.95/100,000 population in 1995 to 2.17/100,000 population in 2016 (Rho = 0.48; p = 0.024).

Discussion: A better understanding of TB features in elderly and its chronological trends overtime would facilitate to put in place, in the national TB control program, strategies geared towards this group of people.

背景:随着预期寿命的逐渐延长,结核病已成为发展中国家老年人的公共卫生问题。目的/目的:本研究旨在分析突尼斯南部老年人结核病的预后因素和时间趋势。方法:进行回顾性研究。纳入1995年至2016年间结核病控制中心记录的所有年龄≥60岁的结核病患者。通过计算Spearman(Rho)的相关系数分析TB的时间趋势。多元分析采用二元逻辑回归(调整后的比值比(AOR);CI;p) 以确定与老年人不成功结局相关的独立风险因素。A p值结果:总体而言,1995年至2016年间,报告了512例新的老年结核病病例,平均每年新增23.3例。老年人的平均结核病发病率为2.31/100000人口/年。病死率为8.6%。多因素分析显示,与老年患者不成功结局独立相关的因素是年龄在80至89岁之间(AOR=4.5;[95%CI:210.2];p<0.001),男性(AOR=2.2;[95%CI:1.1,4.4];p=0.026)和神经脑膜受累(AOR=4.6;[95%CI:1.414.8];p=0.011)。老年患者的结核病发病率从1995年的0.95/100000人口显著增加到2016年的2.17/100000人口(Rho=0.48;p=0.024)促进在国家结核病控制计划中落实针对这一群体的战略。
{"title":"Tuberculosis in elderly: Epidemiological profile, prognosis factors and chronological trends in Southern Tunisia, 1995-2016.","authors":"Maroua Trigui,&nbsp;Houda Ben Ayed,&nbsp;Makram Koubaa,&nbsp;Mariem Ben Hmida,&nbsp;Maissa Ben Jmaa,&nbsp;Sourour Yaich,&nbsp;Tarek Ben Jmaa,&nbsp;Fatma Hammami,&nbsp;Habib Fki,&nbsp;Jamel Damak,&nbsp;Mounir Ben Jemaa","doi":"10.1177/17571774221127540","DOIUrl":"10.1177/17571774221127540","url":null,"abstract":"<p><strong>Background: </strong>Tuberculosis (TB) has become a public health problem among elderly in developing countries with the gradual increase in life expectancy.</p><p><strong>Aim/objective: </strong>This study aimed to analyze the prognosis factors and chronological trends of TB in elderly in Southern Tunisia.</p><p><strong>Methods: </strong>A retrospective study was conducted. All TB patients aged ≥60 years, recorded in the Center of TB Control between 1995 and 2016, were included. Chronological trends of TB were analyzed by calculating the correlation coefficient of Spearman (Rho). Multivariate analysis was done by binary logistic regression (Adjusted Odds ratio (AOR); CI; <i>p</i>) to determine the independent risk factors associated with unsuccessful outcome in elderly. A <i>p</i> value <0.05 was considered as statistically significant.</p><p><strong>Results: </strong>Overall, 512 new elderly TB cases were notified between 1995 and 2016, with an average of 23.3 new cases/year. The mean TB incidence rate for elderly was 2.31/100,000 population/year. The case-fatality rate of 8.6%. Multivariate analysis showed that factors independently associated with unsuccessful outcome among elderly patients were age between 80 and 89 (AOR = 4.5; [95% CI: 2, 10.2]; <i>p</i> < 0.001), male gender (AOR = 2.2; [95% CI: 1.1, 4.4]; <i>p</i> = 0.026) and neuro-meningeal involvement (AOR = 4.6; [95% CI: 1.4, 14.8]; <i>p</i> = 0.011). The incidence of TB in elderly patients increased significantly from 0.95/100,000 population in 1995 to 2.17/100,000 population in 2016 (Rho = 0.48; <i>p</i> = 0.024).</p><p><strong>Discussion: </strong>A better understanding of TB features in elderly and its chronological trends overtime would facilitate to put in place, in the national TB control program, strategies geared towards this group of people.</p>","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":"23 6","pages":"255-262"},"PeriodicalIF":1.2,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583438/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40568893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aspergillus in COVID-19 intensive care unit; what is lurking above your head? COVID-19重症监护病房中的曲霉;什么潜伏在你的头上?
IF 1.2 Q4 INFECTIOUS DISEASES Pub Date : 2022-11-01 Epub Date: 2022-09-14 DOI: 10.1177/17571774221127548
Sue Dailly, Erin Boatswain, Julie Brooks, Glen Campbell, Katy Dallow, Ahilanandan Dushianthan, Sarah Glover, Melanie Griffiths, Sanjay Gupta, James Austin, Robert Chambers, Sarah Jeremiah, Charlotte Morris, Nitin Mahobia, Martyn Poxon, Alison Rickman, Helen Jaques, Tatshing Yam, Kordo Saeed

Introduction: Through routine respiratory samples surveillance among COVID-19 patients in the intensive care, three patients with aspergillus were identified in a newly opened general intensive care unit during the second wave of the pandemic.

Methodology: As no previous cases of aspergillus had occurred since the unit had opened. An urgent multidisciplinary outbreak meeting was held. The possible sources of aspergillus infection were explored. The multidisciplinary approach enabled stakeholders from different skills to discuss possible sources and management strategies. Environmental precipitants like air handling units were considered and the overall clinical practice was reviewed. Settle plates were placed around the unit to identify the source. Reports of recent water leaks were also investigated.

Results: Growth of aspergillus on a settle plate was identified the potential source above a nurse's station. This was the site of a historic water leak from the ceiling above, that resolved promptly and was not investigated further. Subsequent investigation above the ceiling tiles found pooling of water and mould due to a slow water leak from a pipe.

Conclusion: Water leaks in patient areas should be promptly notified to infection prevention. Detailed investigation to ascertain the actual cause of the leak and ensure any remedial work could be carried out swiftly. Outbreak meetings that include diverse people with various expertises (clinical and non-clinical) can enable prompt identification and resolution of contaminated areas to minimise risk to patients and staff. During challenging pandemic periods hospitals must not lose focus on other clusters and outbreaks occurring simultaneously.

通过对重症监护病房的COVID-19患者进行常规呼吸样本监测,在第二次大流行期间新开设的普通重症监护病房中发现了3例曲霉患者。方法学:由于此前没有曲霉菌的情况下,该单位已开放。召开了紧急多学科疫情会议。探讨了曲霉感染的可能来源。多学科方法使不同技能的利益相关者能够讨论可能的资源和管理策略。考虑了空气处理装置等环境沉淀剂,并对整体临床实践进行了回顾。在装置周围放置沉淀板以确定来源。最近有关漏水的报道也得到了调查。结果:在一个护士站上方的固定板上发现了曲霉生长的潜在来源。这是一个历史性的从天花板漏水的地方,很快就解决了,没有进一步调查。随后的调查发现,由于管道缓慢漏水,天花板上方出现了积水和霉菌。结论:患者区发生漏水应及时通报,预防感染。进行详细调查,以确定泄漏的实际原因,并确保任何补救工作能够迅速进行。由具有各种专业知识(临床和非临床)的不同人员参加的疫情会议可以迅速确定和解决污染区域,从而最大限度地减少对患者和工作人员的风险。在具有挑战性的大流行期间,医院不能失去对同时发生的其他群集和疫情的关注。
{"title":"Aspergillus in COVID-19 intensive care unit; what is lurking above your head?","authors":"Sue Dailly,&nbsp;Erin Boatswain,&nbsp;Julie Brooks,&nbsp;Glen Campbell,&nbsp;Katy Dallow,&nbsp;Ahilanandan Dushianthan,&nbsp;Sarah Glover,&nbsp;Melanie Griffiths,&nbsp;Sanjay Gupta,&nbsp;James Austin,&nbsp;Robert Chambers,&nbsp;Sarah Jeremiah,&nbsp;Charlotte Morris,&nbsp;Nitin Mahobia,&nbsp;Martyn Poxon,&nbsp;Alison Rickman,&nbsp;Helen Jaques,&nbsp;Tatshing Yam,&nbsp;Kordo Saeed","doi":"10.1177/17571774221127548","DOIUrl":"https://doi.org/10.1177/17571774221127548","url":null,"abstract":"<p><strong>Introduction: </strong>Through routine respiratory samples surveillance among COVID-19 patients in the intensive care, three patients with aspergillus were identified in a newly opened general intensive care unit during the second wave of the pandemic.</p><p><strong>Methodology: </strong>As no previous cases of aspergillus had occurred since the unit had opened. An urgent multidisciplinary outbreak meeting was held. The possible sources of aspergillus infection were explored. The multidisciplinary approach enabled stakeholders from different skills to discuss possible sources and management strategies. Environmental precipitants like air handling units were considered and the overall clinical practice was reviewed. Settle plates were placed around the unit to identify the source. Reports of recent water leaks were also investigated.</p><p><strong>Results: </strong>Growth of aspergillus on a settle plate was identified the potential source above a nurse's station. This was the site of a historic water leak from the ceiling above, that resolved promptly and was not investigated further. Subsequent investigation above the ceiling tiles found pooling of water and mould due to a slow water leak from a pipe.</p><p><strong>Conclusion: </strong>Water leaks in patient areas should be promptly notified to infection prevention. Detailed investigation to ascertain the actual cause of the leak and ensure any remedial work could be carried out swiftly. Outbreak meetings that include diverse people with various expertises (clinical and non-clinical) can enable prompt identification and resolution of contaminated areas to minimise risk to patients and staff. During challenging pandemic periods hospitals must not lose focus on other clusters and outbreaks occurring simultaneously.</p>","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":"23 6","pages":"278-284"},"PeriodicalIF":1.2,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475376/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40566400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diary. 日记。
IF 1.2 Q4 INFECTIOUS DISEASES Pub Date : 2022-09-01 DOI: 10.1177/17571774221114364
{"title":"Diary.","authors":"","doi":"10.1177/17571774221114364","DOIUrl":"https://doi.org/10.1177/17571774221114364","url":null,"abstract":"","PeriodicalId":16094,"journal":{"name":"Journal of Infection Prevention","volume":"23 5","pages":"250"},"PeriodicalIF":1.2,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393599/pdf/10.1177_17571774221114364.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10123839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Infection Prevention
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1